Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Jornal de Pediatria

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpeds.2016.12.078PMID 28209292
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Does Length of Developmental Behavioral Pediatrics Training Matter?

  2017cited by this paper
• Do On-Site Mental Health Professionals Change Pediatricians' Responses to Children's Mental Health Problems?

  2016cited by this paper
• Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.

  2016cited by this paper
• Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)

  2016cited by this paper
• Temporal trends in lipid screening and therapy among youth from 2002 to 2012.

  2015cited by this paper
• Physicians’ Lack of Adherence to National Heart, Lung, and Blood Institute Guidelines for Pediatric Lipid Screening

  2015cited by this paper
• Universal cholesterol screening of children in community-based ambulatory pediatric clinics.

  2015cited by this paper
• Lipid Screening in Children and Adolescents in Community Practice: 2007 to 2010

  2014cited by this paper
• Implementation of lipid screening guidelines in children by primary pediatric providers.

  2014cited by this paper
• Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation.

  2014cited by this paper
• Cholesterol testing among children and adolescents during health visits.

  2014cited by this paper
• NHLBI Integrated Guidelines on Cardiovascular Disease Risk Reduction: can we clarify the controversy about cholesterol screening and treatment in childhood?

  2012cited by this paper
• Universal screening and drug treatment of dyslipidemia in children and adolescents.

  2012cited by this paper
• Is universal pediatric lipid screening justified?

  2012cited by this paper
• Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report

  2011cited by this paper
• Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.

  2011cited by this paper
• Lipid Screening and Cardiovascular Health in Childhood

  2008cited by this paper
• Screening and Treatment for Lipid Disorders in Children and Adolescents: Systematic Evidence Review for the US Preventive Services Task Force

  2007cited by this paper
• Response rates and response bias for 50 surveys of pediatricians.

  2005cited by this paper
• National Trends in the Management of Cardiovascular Disease Risk Factors in Children: Second NHLBI Survey of Primary Care Physicians

  1998cited by this paper
• Management of cardiovascular disease risk factors in children. A national survey of primary care physicians.

  1990cited by this paper
• Management of Cardiovascular Disease Risk Factors in Children: A National Survey of Primary Care Physicians

  1990cited by this paper

• Update on familial hypercholesterolemia: An expert clinical consensus from the National Lipid Association.

  2026cites this paper
• Familial Hypercholesterolemia Screening in Childhood and Early Adulthood: A Cost-Effectiveness Study.

  2025cites this paper
• Adolescent Nutrition and Health: a Critical Period for Nutritional Intervention to Prevent Long Term Health Consequences

  2025cites this paper
• Current practices, attitudes and barriers to paediatric lipid screening and management amongst Family Physicians and Paediatricians in British Columbia.

  2025cites this paper
• Accelerating Guideline Recommended Universal Pediatric Lipid Screening: Launch of the LEAD Pediatric Initiative.

  2025cites this paper
• State-of-the-art review: The value of leveraging evidence and data (LEAD) in pediatric screening for familial hypercholesterolemia

  2025cites this paper
• Improving Preteen Lipid Screening Rates at Well-Child Visits Through Quality Improvement Methods.

  2025cites this paper
• Health Disparities in Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.

  2025cites this paper
• A multicenter trial to test pitavastatin calcium in youth with combined dyslipidemia of obesity: Design, implementation, challenges, and responses.

  2025cites this paper
• Genetic and Ethnic Determinants of Dyslipidemia in Women: Clinical Trials in Lipid Management, Where are Women?

  2025cites this paper
• Diagnóstico del estado nutricional, dislipidemia y factores de riesgo asociados en escolares indígenas yaquis

  2024cites this paper
• Lipoprotein(a) serum concentrations in children in relation to body mass index, age and sex

  2024cites this paper
• Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.

  2024cites this paper
• Comparison of Clinical Decision Support Tools to Improve Pediatric Lipid Screening.

  2024cites this paper
• The Importance of Genetic Testing for Familial Hypercholesterolemia: A Pediatric Pilot Study

  2024cites this paper
• Myopathy in Statin-Treated Children and Adolescents: A Practical Approach

  2024cites this paper
• Patient and healthcare professional perspective on challenges in lipid profile management in dyslipidemia patients: Two separate cross-sectional surveys

  2024cites this paper
• “I don’t think people should die young”: perspectives of parents with children diagnosed with familial hypercholesterolemia

  2024cites this paper
• Pediatric Lipid Screening Prevalence Using Nationwide Electronic Medical Records

  2024cites this paper
• The Role of Reverse Cascade Screening in Children with Familial Hypercholesterolemia: A Literature Review and Analysis

  2024cites this paper
• Improvement Science Increases Routine Lipid Screening in General Pediatric Cardiology.

  2024cites this paper
• The Role of Blood Testing in Prevention, Diagnosis, and Management of Chronic Diseases: A Review.

  2024cites this paper
• Overcoming the real and imagined barriers to cholesterol screening in pediatrics.

  2024cites this paper
• Islet autoantibody screening in at-risk adolescents to predict type 1 diabetes until young adulthood: a prospective cohort study.

  2023cites this paper
• Universal lipid screening in adolescents to identify familial hypercholesterolemia in a large healthcare system.

  2023cites this paper
• Tracking of apolipoprotein B levels measured in childhood and adolescence: systematic review and meta-analysis

  2023cites this paper
• Childhood Non-HDL Cholesterol and LDL Cholesterol and Adult Atherosclerotic Cardiovascular Events

  2023cites this paper
• Cholesterol screening and intervention in youth - It's time to move on.

  2023cites this paper
• A proposed pediatric clinical cardiovascular health reference standard.

  2023cites this paper
• Cholesterol Screening in Children: Is a Universal Approach Working?

  2023cites this paper
• Toward a Roadmap for Best Practices in Pediatric Preventive Cardiology: A Science Advisory From the American Heart Association

  2023cites this paper
• Algorithms for Treating Dyslipidemia in Youth

  2023cites this paper
• Adolescents cholesterol passport: a universal pediatric lipid screening tool to combat atherosclerosis—the world's deadliest scourge

  2023cites this paper
• Electrochemical detection of cholesterol in human biofluid using microneedle sensor.

  2023cites this paper
• Adolescent nutrition and health - characteristics, risk factors, and opportunities of an overlooked life stage.

  2023cites this paper
• Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone?

  2023cites this paper
• Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

  2023cites this paper
• Update on management of paediatric dyslipidaemia

  2023cites this paper
• Universal Lipid Screening Among 9- to 11-Year-Old Children: Screening Results and Physician Management

  2022cites this paper
• Prevention of atherosclerosis from childhood

  2022cites this paper
• Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices

  2022cites this paper
• A life-course approach to cardiovascular disease prevention

  2022cites this paper
• A scoping review of interventions increasing screening and diagnosis of familial hypercholesterolemia.

  2022cites this paper
• Long-term tracking and population characteristics of lipoprotein (a) in the Cardiovascular Risk in Young Finns Study.

  2022cites this paper
• Increasing lipid screenings in children 9-11 years old at a federally qualified health center - A quality improvement project.

  2022cites this paper
• Lack of age-appropriate reference intervals causing potentially missed alerts in clinical reports of dyslipidemia.

  2022cites this paper
• Pediatric Infection-Induced SARS-CoV-2 Seroprevalence Increases and Seroprevalence by Type of Clinical Care—September 2021-February 2022

  2022cites this paper
• Key domain 4: Placing cardiovascular health at the heart of health and climate policies

  2022cites this paper
• SLCO1B1 Pharmacogenetics in Pediatrics

  2022cites this paper
• Screening and Management of Dyslipidemia in Children and Adolescents

  2022cites this paper
• Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood

  2022cites this paper
• Familial Hypercholesterolaemia as a Model for Evaluating the Ethics of Population Testing and Screening for Genetic Disease

  2021cites this paper
• Cascade Screening and Treatment Initiation in Young Adults with Heterozygous Familial Hypercholesterolemia

  2021cites this paper
• Outcomes from a pilot genetic counseling intervention using motivational interviewing and the extended parallel process model to increase cascade cholesterol screening

  2021cites this paper
• Improving Compliance with Dyslipidemia Screening Guidelines in a Single-center U.S. Outpatient Pediatric Cardiology Clinic

  2021cites this paper
• Development of an Implementation Framework for Overcoming Underdiagnoses of Familial Hypercholesterolemia in the USA

  2021cites this paper
• Helping young women go red: Harnessing the power of personal and digital information to prevent heart disease.

  2021cites this paper
• Universal Cholesterol Screening Among Pediatric Primary Care Providers Within California and Minnesota: A Qualitative Assessment of Barriers and Facilitators.

  2021cites this paper
• Contemporary outcomes studies to identify and mitigate the risk in patients with premature cardiovascular disease

  2021cites this paper
• Association of Non-High-Density Lipoprotein Cholesterol Measured in Adolescence, Young Adulthood, and Mid-Adulthood With Coronary Artery Calcification Measured in Mid-Adulthood.

  2021cites this paper
• Pediatric Dyslipidemia and Screening Recommendations

  2021cites this paper
• Promoting Ideal Cardiovascular Health Through the Life Span

  2020cites this paper
• Pediatric cholesterol screening practices in 9- to 11-year-olds in a large midwestern primary care setting.

  2020cites this paper
• Parental Knowledge and Attitudes About Universal Lipid Screening Among Children Aged 9 to 11 Years

  2020cites this paper
• Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

  2020cites this paper
• Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

  2020cites this paper
• Life Course Developmental Approach to Cardiovascular Health and Cardiovascular Disease Prevention: Opportunities and Unanswered Questions.

  2020cites this paper
• Adherence with lipid screening guidelines in standard- and high-risk children and adolescents.

  2020cites this paper
• Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE FH Registry.

  2020cites this paper
• Should Lipoprotein(a) be Measured in Youth?

  2020cites this paper
• Women Living with Familial Hypercholesterolemia: Challenges and Considerations Surrounding Their Care

  2020cites this paper
• Young Women's Perceptions of Heart Disease Risk.

  2020cites this paper
• Effectiveness and Safety of Statin Therapy in Children: A Real-World Clinical Practice Experience

  2020cites this paper
• Risk Factors For Coronary Artery Disease

  2020cites this paper
• Pediatric Lipid Screening and Treatment in Canada: Practices, Attitudes, and Barriers.

  2020cites this paper
• Characteristics of Children Referred to a Lipid Clinic Before and After the Universal Screening Guidelines

  2019cites this paper
• Factors Affecting Pediatric Dyslipidemia Screening and Treatment

  2019cites this paper
• Effectiveness of early identification and electronic interventions for teens with risk factors for the development of heart disease and diabetes: Phase II findings

  2019cites this paper
• Trends in Levels of Lipids and Apolipoprotein B in US Youths Aged 6 to 19 Years, 1999-2016.

  2019cites this paper
• Quality Improvement Intervention for Universal Lipid Screening in Children Aged 9 to 11 Years

  2019cites this paper
• Temporal trends in pediatric and young adult lipid testing and treatment and cost-effectiveness analysis of universal vs. pediatric lipid screening methodology in the U.S.

  2019cites this paper
• Pediatric heterozygous familial hypercholesterolemia patients have locally increased aortic pulse wave velocity and wall thickness at the aortic root

  2019cites this paper
• Routine cholesterol tests and subsequent change in BMI among overweight and obese children.

  2019cites this paper
• Screening and Referral for Low-Income Families' Social Determinants of Health by US Pediatricians.

  2019cites this paper
• US Pediatrician Practices and Attitudes Concerning Childhood Obesity: 2006 and 2017.

  2019cites this paper
• HIV and cART-Associated Dyslipidemia Among HIV-Infected Children

  2019cites this paper
• A Pilot Study of School‐Based Comprehensive Cardiovascular Screening in Middle School Children

  2019cites this paper
• Obesity, Hypertension, and Dyslipidemia in Childhood Are Key Modifiable Antecedents of Adult Cardiovascular Disease: A Call to Action

  2018cites this paper
• Parent–child genetic testing for familial hypercholesterolaemia in an Australian context

  2018cites this paper
• Management of Hypertension and High Low‐Density Lipoprotein in Pediatric Type 1 Diabetes

  2018cites this paper
• A national survey of primary care physicians: Perceptions and practices of low-dose CT lung cancer screening

  2018cites this paper
• An Electrochemical Cholesterol Biosensor Based on A CdTe/CdSe/ZnSe Quantum Dots—Poly (Propylene Imine) Dendrimer Nanocomposite Immobilisation Layer

  2018cites this paper
• Dyslipidemia Screening in Children between the Ages of 9 and 11 Years: An Evidence-Based Approach

  2018cites this paper
• The evolving model of care for familial hypercholesterolaemia

  2017cites this paper
• Lipid Screening and Treatment Practices Conflict With Conflicting Recommendations: Where Do We Go From Here?

  2017cites this paper
• An enquiry based on a standardised questionnaire into knowledge, awareness and preferences concerning the care of familial hypercholesterolaemia among primary care physicians in the Asia-Pacific region: the “Ten Countries Study”

  2017cites this paper
• The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease

  2017cites this paper
• Knowns and unknowns in the care of pediatric familial hypercholesterolemia

  2017cites this paper
• Temporal trends in lipid testing among children and adolescents: A population based study

  2017cites this paper
• Guidelines for Screening, Prevention, Diagnosis and Treatment of Dyslipidemia in Children and Adolescents

  2016influential citation